Literature DB >> 1448789

The acute effect of a single very high dose of N-3 fatty acids on coagulation and fibrinolysis.

J M Møller1, N Svaneborg, H H Lervang, K Varming, P Madsen, J Dyerberg, E B Schmidt.   

Abstract

The objective of the study was to investigate the acute effect of a single very high dose of n-3 PUFA on coagulation and fibrinolysis. Forty healthy volunteers were randomized into two groups to receive either 20 grams of n-3 PUFA or 20 grams of n-6 PUFA as a single dose at 6 p.m. with their evening meal. Coagulation and fibrinolysis were evaluated in the fasting state at 8 a.m. the next morning and compared to values obtained at 8 a.m. the day before, when the participants were on their habitual diets. PAI-1 activity in plasma increased by a mean of 62% in subjects randomized to receive n-3 PUFA despite that no changes could be demonstrated in t-PA antigen levels. PAI-1 activity was unaltered in the 20 controls receiving n-6 PUFA. Plasma fibrinogen, coagulation factor VII, thrombin-antithrombin complexes and D-dimer did not significantly change after either supplement. The substantial increase in levels of PAI-1 activity in plasma after a single very high dose of n-3 PUFA may limit the usefulness of single very high doses of n-3 PUFA in acute clinical conditions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1448789     DOI: 10.1016/0049-3848(92)90017-5

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

Review 1.  Lifestyle, fibrinolysis and lipids.

Authors:  E J Brommer; J A Gevers Leuven; P Brakman
Journal:  Pharm World Sci       Date:  1997-04

2.  Omega-3 Ethyl Ester Concentrate Decreases Total Apolipoprotein CIII and Increases Antithrombin III in Postmyocardial Infarction Patients.

Authors:  E Swahn; H von Schenck; A G Olsson
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

Review 3.  Omega-3 fatty acids. Current status in cardiovascular medicine.

Authors:  E B Schmidt; J Dyerberg
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.